Industry experts on US 1022 e-cigarette seizure: Leading companies targeted, brands urged to secure STN numbers early

Oct.23.2024
Industry experts on US 1022 e-cigarette seizure: Leading companies targeted, brands urged to secure STN numbers early
In response to the "U.S. 1022 E-Cigarette Seizure Incident", 2Firsts reached out to several industry experts to gather comprehensive analysis and expert insight from multiple perspectives.

Disclaimer: The content presented in this article represents the personal opinions of the interviewee and does not necessarily reflect the position or views of 2Firsts. 2Firsts makes no warranties or representations as to the accuracy, completeness, timeliness and applicability of the information, data, analysis and conclusions contained in the article. Readers are advised to make their own independent judgements based on official sources when relying on the information in this article.

 

The US Food and Drug Administration (FDA) announced on 22 October that it was working with US Customs and Border Protection (CBP) to administratively detain approximately 3 million unauthorised e-cigarette products with an estimated retail value of $76 million. To gain a comprehensive analysis and professional insight from different perspectives, 2Firsts reached out to several industry experts for more information.

 

 

Logistics and freight experts: E-cigarette brands should secure STN numbers early as FDA and CBP have different inspection priorities

 

 

A long-time industry professional in the freight forwarding industry with business dealings in the American market told 2Firsts that in light of the recent seizure incident, logistics freight forwarders have made special adjustments in handling import operations and are currently taking a wait-and-see approach overall. He mentioned that the main adjustment is to make reasonable declarations and that "after being educated by the market, the practice of over-declaring and taking on too much will decrease in the future.

 

In response to the strict compliance requirements in the US, industry experts point out that FDA and CBP inspections focus on different aspects. The FDA primarily checks whether products have been properly declared to the FDA or can provide an STN code, while CBP inspections focus more on checking whether quantities have been under-declared and whether the declared value is correct. Put simply, CBP inspections are aimed at preventing tax evasion and fraudulent behaviour.

 

When discussing how to ensure compliance and smooth clearance of imported products, industry experts noted that regulations are becoming more stringent, making compliance declarations even more important. They advise that in the future, brands producing flavoured e-cigarettes should apply for the FDA's PMTA and obtain an STN as early as possible. When applying, it is advisable to use your own importer in the US, pay taxes sensibly and avoid tax risks.

 

 

Compliance industry experts: FDA prepares for full implementation of STN numbering law with stepped-up enforcement

 

 

In response to this incident, a compliance industry professional familiar with the PMTA review mechanism said, "The FDA's actions this time are not very surprising. Because the FDA has had STN submissions for a long time". 

 

He suggested that this is the FDA laying the groundwork for full implementation of the STN law, signalling more stringent regulation of the e-cigarette market in the future.
 

Industry sources have highlighted details of the FDA's latest crackdown. According to the FDA's announcement, most of the unauthorised e-cigarettes are intentionally mislabelled as items unrelated to e-cigarettes, a common practice known in the industry as the "grey market".

 

At the same time, he believes that this joint action by the FDA and CBP is aimed at deterring illegal e-cigarette imports.

 

"The FDA highlighted its ability to work with CBP to identify and intercept large volumes of misdeclared shipments. With the implementation of the STN number requirement, the likelihood of illegal grey market entry will be significantly reduced. All goods must be properly declared with an STN number to be matched with the PMTA documents submitted to ensure legal entry," he added.

 

The industry expert predicts that the FDA will increase its enforcement efforts, particularly targeting products that may appeal to minors. Companies are advised to actively apply for PMTAs and ensure that their products do not attract young consumers to avoid becoming a focus of regulatory enforcement.

 

 

Test agency staff: Top companies targeted - companies must ensure compliance

 

 

According to Ms Liu, Sales Director of Weber Testing, the FDA's recent significant action means that the future testing and regulation of e-cigarette products is an important issue, involving the quality, safety and maintenance of market order of the products.

 

Due to geopolitical reasons and the proliferation of Chinese companies in recent years, some actions taken by the FDA may be seen as protecting domestic trade interests, with top companies easily targeted. As a regulatory agency, it is important to emphasise the importance of companies actively cooperating and operating in a legal and compliant manner," she added.

 

Mr Luo of Lixun Testing pointed out that some companies face problems when submitting PMTA applications. He said, "Some companies submit incomplete and non-standard materials when applying for PMTA, resulting in rejection during the review process. This requires continuous resubmission, which is very time consuming.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | Philip Morris Japan Launches Ginza-Exclusive IQOS ILUMA i PRIME, Limited to 1,814 Units at First Global Flagship
Product | Philip Morris Japan Launches Ginza-Exclusive IQOS ILUMA i PRIME, Limited to 1,814 Units at First Global Flagship
Philip Morris Japan (PMJ) launched the IQOS ILUMA i PRIME Ginza Limited Model Set in Tokyo on September 4, 2026, alongside the opening of IQOS Flagship Ginza, the brand’s first global flagship store. The Oasis Blue edition is limited to 1,814 individually numbered units, with the figure derived from the store’s address at Ginza 1-8-14. The set also includes two Yamanaka-nuri glasses and special packaging, priced at JPY 11,980 and sold exclusively at the Ginza flagship.
Sep.07
China Tobacco Zhejiang files patent for pressure-triggered, on-demand oral nicotine release
China Tobacco Zhejiang files patent for pressure-triggered, on-demand oral nicotine release
China Tobacco Zhejiang Industrial Co., Ltd. has filed a patent application for an oral nicotine delivery product designed to let users actively adjust nicotine release. The product embeds two types of nicotine reservoirs with different wall thicknesses and positions inside a deformable matrix. Pressure applied with the tongue or lips can rupture the reservoirs and accelerate nicotine release. In simulated oral tests, several patent examples showed sharply higher peak nicotine release rates as applied force increased from 0 N to 1 N and 3 N. The filing explores a shift from preset release profiles toward user-triggered nicotine delivery.
Sep.01
Australia Brings in Deloitte to Support Illicit Tobacco and Vape Enforcement Across Data, Processes and Project Delivery
Australia Brings in Deloitte to Support Illicit Tobacco and Vape Enforcement Across Data, Processes and Project Delivery
Australia’s Department of Home Affairs has hired Deloitte to provide data analytics, business-process, communications and project-delivery support to the Office of the Illicit Tobacco and E-Cigarette Commissioner. The government says Deloitte personnel do not provide policy advice to the Commissioner or the Australian government, with policy development and decision-making remaining with public officials. The arrangement has nevertheless drawn scrutiny because Deloitte has previously provided professional services to several tobacco and vaping companies.
Sep.03
Couche-Tard Posts Double-Digit U.S. Same-Store Growth in Other Nicotine Products, Led by Pouches
Couche-Tard Posts Double-Digit U.S. Same-Store Growth in Other Nicotine Products, Led by Pouches
Alimentation Couche-Tard said U.S. same-store sales in its “other nicotine products” category grew at a double-digit rate in the first quarter of fiscal 2027, led by nicotine pouches, while overall U.S. same-store merchandise revenues increased 1.7%. The company also said its Canadian nicotine business continued to face regulatory pressure and illicit-market headwinds. The U.S. performance coincides with Couche-Tard's participation in efforts to reopen Canadian convenience-store access to authorized nicotine pouches, though the company has not established a direct causal link between the two.
Sep.14
U.S. Military Could Test Nicotine Pouches and Vapes for Smoking Cessation as Washington Examiner Cites ZYN and Potential $4 Billion Reduction in Related Defense Costs
U.S. Military Could Test Nicotine Pouches and Vapes for Smoking Cessation as Washington Examiner Cites ZYN and Potential $4 Billion Reduction in Related Defense Costs
The House-passed FY2027 National Defense Authorization Act includes a provision authorizing the defense secretary to conduct a one-year smoking-cessation pilot for active-duty service members. Section 707 lists counseling, nicotine gum and patches alongside what the bill calls "electric nicotine delivery systems," nicotine pouches and heat-not-burn products. A recent Washington Examiner op-ed cited ZYN as an example in arguing for the provision, but the legislation does not name any commercial brand or supplier. ZYN is made by PMI-owned Swedish Match USA, with specified products holding FDA marketing authorizations and modified risk orders.
Sep.20
JTI Proposes 25-Cent Irish Cigarette Tax Increase, Says It Could Raise €45 Million
JTI Proposes 25-Cent Irish Cigarette Tax Increase, Says It Could Raise €45 Million
Japan Tobacco International's Irish business has proposed a €0.25 tax increase on a pack of 20 cigarettes in its pre-Budget 2027 submission, below the €0.50-or-more increases typically imposed in recent Irish budgets. JTI says the proposal could generate around €45 million in additional Exchequer revenue while limiting further movement toward illicit and non-Irish-tax-paid tobacco. Revenue's existing estimate for a comparable €0.25 increase, including pro-rata rises on other tobacco products, is about €18 million for a full year.
JTI
Sep.18 by 2Firsts Perspectives